(Q39463659)

English

Optimized quantities of GDNF overexpressed by engineered astrocytes are critical for protection of neuroblastoma cells against 6-OHDA toxicity

scientific article published on 4 October 2011

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Optimized quantities of GDNF overexpressed by engineered astrocytes are critical for protection of neuroblastoma cells against 6-OHDA toxicity (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Roya Safi

1

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Mossa Gardaneh

2

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Yasin Panahi

3

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Nader Maghsoudi

4

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Mohammad Zaefizadeh

5

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Ehsan Gharib

6

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

publication date

4 October 2011

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Journal of Molecular Neuroscience

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

46

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

654-665

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

The GDNF family: signalling, biological functions and therapeutic value

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Towards a neuroprotective gene therapy for Parkinson's disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Motoneurons crave glial cell line-derived neurotrophic factor

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Neurons depend on astrocytes in a coculture system for protection from glutamate toxicity

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

GDNF treatment in Parkinson's disease: time for controlled clinical trials?

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Lentiviral vector-mediated genetic modification of human neural progenitor cells for ex vivo gene therapy

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Ontogeny and distribution of glial cell line-derived neurotrophic factor (GDNF) mRNA in rat.

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Astrocyte delivery of glial cell line-derived neurotrophic factor in a mouse model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Emerging restorative treatments for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Astrocyte protection of neurons: role of transforming growth factor-beta signaling via a c-Jun-AP-1 protective pathway

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Rho kinase inhibitor Fasudil induces neuroprotection and neurogenesis partially through astrocyte-derived G-CSF.

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Glutathione pathways in the brain.

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Long-term restoration of nigrostriatal system function by implanting GDNF genetically modified fibroblasts in a rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Ex vivo delivery of GDNF maintains motor function and prevents neuronal loss in a transgenic mouse model of Huntington's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Ex vivo gene delivery of GDNF using primary astrocytes transduced with a lentiviral vector provides neuroprotection in a rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Continuous low-level glial cell line-derived neurotrophic factor delivery using recombinant adeno-associated viral vectors provides neuroprotection and induces behavioral recovery in a primate model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Grafts of extra-adrenal chromaffin cells as aggregates show better survival rate and regenerative effects on parkinsonian rats than dispersed cell grafts

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Synergy between glutathione peroxidase-1 and astrocytic growth factors suppresses free radical generation and protects dopaminergic neurons against 6-hydroxydopamine

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Aberrant sprouting and downregulation of tyrosine hydroxylase in lesioned nigrostriatal dopamine neurons induced by long-lasting overexpression of glial cell line derived neurotrophic factor in the striatum by lentiviral gene transfer

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

GDNF therapy for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Intravenous administration of glial cell line-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult rat

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Conditioned medium from aged monkey fibroblasts stably expressing GDNF and BDNF improves survival of embryonic dopamine neurons in vitro

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

GDNF delivery using human neural progenitor cells in a rat model of ALS.

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Intracerebral infusion of glial cell line-derived neurotrophic factor promotes striatal neurogenesis after stroke in adult rats

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Challenges in Parkinson's disease: restoration of the nigrostriatal dopamine system is not enough

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Glial cell line-derived neurotrophic factor induces neuronal sprouting in human brain

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Viral vectors for in vivo gene transfer in Parkinson's disease: properties and clinical grade production.

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Cloning and structural organization of the gene encoding the mouse glial cell line-derived neurotrophic factor, GDNF.

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Structural and functional neuroprotection in a rat model of Huntington's disease by viral gene transfer of GDNF.

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Intramuscular grafts of myoblasts genetically modified to secrete glial cell line-derived neurotrophic factor prevent motoneuron loss and disease progression in a mouse model of familial amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Convective delivery of glial cell line-derived neurotrophic factor in the human putamen

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Promotion of survival and regeneration of nigral dopamine neurons in a rat model of Parkinson's disease after implantation of embryonal carcinoma-derived neurons genetically engineered to produce glial cell line-derived neurotrophic factor

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD.

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Astrocyte-derived transgene GDNF promotes complete and long-term survival of adult facial motoneurons following avulsion and differentially regulates the expression of transcription factors of AP-1 and ATF/CREB families

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Intraputamenal infusion of glial cell line-derived neurotrophic factor in PD: a two-year outcome study.

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Expression of GDNF transgene in astrocytes improves cognitive deficits in aged rats.

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Tight control of transgene expression by lentivirus vectors containing second-generation tetracycline-responsive promoters.

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Microcapsules prepared with different biomaterials to immobilize GDNF secreting 3T3 fibroblasts

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Long-term striatal overexpression of GDNF selectively downregulates tyrosine hydroxylase in the intact nigrostriatal dopamine system

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Astrocyte-secreted GDNF and glutathione antioxidant system protect neurons against 6OHDA cytotoxicity

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Novel functions and signalling pathways for GDNF.

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Viral vectors, animal models and new therapies for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Crossroads in GDNF therapy for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Unilateral intraputamenal glial cell line-derived neurotrophic factor in patients with Parkinson disease: response to 1 year of treatment and 1 year of withdrawal

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Nurr1-RXR heterodimers mediate RXR ligand-induced signaling in neuronal cells.

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Delayed delivery of AAV-GDNF prevents nigral neurodegeneration and promotes functional recovery in a rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Targets for neuroprotection in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Pitx3-transfected astrocytes secrete brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor and protect dopamine neurons in mesencephalon cultures

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Overexpression of glial cell line-derived neurotrophic factor in the CNS rescues motoneurons from programmed cell death and promotes their long-term survival following axotomy

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Astrocyte-conditioned medium protecting hippocampal neurons in primary cultures against corticosterone-induced damages via PI3-K/Akt signal pathway

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Neuroprotection through delivery of glial cell line-derived neurotrophic factor by neural stem cells in a mouse model of Parkinson's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21969113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

GDNF delivery for Parkinson's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21969113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Time course of nigrostriatal degeneration in parkinson's disease. A detailed study of influential factors in human brain amine analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21969113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nigrostriatal neuronal death in Parkinson's disease--a passive or an active genetically-controlled process?

1 reference

https://pubmed.ncbi.nlm.nih.gov/21969113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glial cell line-derived neurotrophic factor (GDNF) therapy for Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21969113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neurotrophic effects of L-DOPA in postnatal midbrain dopamine neuron/cortical astrocyte cocultures.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21969113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Astrocytes protect oligodendrocyte precursor cells via MEK/ERK and PI3K/Akt signaling

1 reference

https://pubmed.ncbi.nlm.nih.gov/21969113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuronal vulnerability in Parkinson's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21969113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neurotrophic effects of conditioned media of astrocytes isolated from different brain regions on hippocampal and cortical neurons

1 reference

https://pubmed.ncbi.nlm.nih.gov/21969113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12031-011-9654-8

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39463659&oldid=2202904368"